- Kaiser Permanente names SVP, Fresno service area manager
- Nebraska hospital CEO resigns amid allegations of $38K in improper spending
- Northwell’s direct contracting business wants to ‘link up’ with other health systems
- PDS Health among 1st to deploy Epic-integrated AI platform
- CommonSpirit’s 5 targets for judging payer prior auth reform — and its Humana milestone
- LifeBridge names division president
- Private equity struggles in healthcare amid mounting pressures: 5 notes for dentistry
- Who’s actually winning the fight for ASC ownership?
- Why some ASCs are buying their own anesthesia groups
- Hospital Sisters Health System names chief technology officer
- Top Medicare Advantage plans for member satisfaction in 2026: JD Power
- How a 12-hospital system saved millions with an inventory overhaul
- Corporate medicine is burning out 90% of employed physicians: 10 survey findings
- HCA Florida hospital names assistant CFO
- GE HealthCare taps new CFO
- 6-property outpatient portfolio acquired
- Patients deserve every evidence-based option for mental healthcare
- 10 anesthesia controversies in 2026
- The $314K cost of employing a physician
- Who’s driving physician M&A in 2026? 5 deals to know
- 5 ways insurers are undercutting anesthesia payments: ASA
- Prior GLP-1 use doesn’t affect bariatric surgery results: 6 things to know
- Statement on Regulation Crypto Assets: Fit-for-purpose Exemptions for Crypto Market Innovation
- Filling the Regulatory Tank: Regulation Crypto Assets Proposing Release
- Statement on Regulation Crypto Assets
- Dental therapy program enrollment up 533% in 5 years
- Dental assisting program enrollment down 5.2% in 5 years
- Dental hygiene program enrollment up 15% in 5 years
- Surgery Partners ditches its $200M M&A target in favor of de novo growth: 5 things to know
- The dental specialties DSOs will prioritize next
- Statement on Commencement of Appointment Process for Public Company Accounting Oversight Board Seat
- Dental school enrollment in the 10 states with the most dental shortage areas
- How To Protect Yourself During Wildfire Season
- Ballmer Institute lands $125M to expand child behavioral health training nationwide
- Judge weighs whether man charged with killing dentist can act as own attorney
- FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
- Included Health to offer Carrum specialty care for alternative plan members
- 52 behavioral health executive moves to know
- Hospital performance improves in June, but lags 2025
- University of Toledo gets nearly $2M to support behavioral health workforce
- CTA reporting requirements eliminated for most dental practices: 5 things to know
- National Alliance on Mental Illness names chief medical officer
- Pennsylvania opens 24/7 behavioral health crisis center
- Cyber criminals target DSOs, dental groups: 3 updates
- OpenAI boosts mental health safeguards for teens
- UnitedHealthcare expands behavioral coaching to 13 million members
- Kindergarten Vaccine Exemptions Hit Record High, New CDC Data Shows
- Loneliness Is A Health Crisis, But Doctors Alone Can't Cure It, Analysis Argues
- Ousted OHSU Healthcare CEO files lawsuit alleging wrongful termination, discrimination
- JD Power: Member satisfaction with Medicare Advantage plans continues to slide
- AMA applauds updated CMS prior authorization reporting guidance
- Constipation In Space: A New Study Provides Answers
- Social Media Beauty Trends May Up Teens' Exposure To Hormone-Disrupting Chemicals
- HIPAA-compliant marketing platform Ours Privacy lands $15M amid growing pixel concerns
- Pharma commercialization partner Valeris brings in new strategy chief
- Biokin bispecific ADC iza-bren hits goal in lung cancer trial, boosting case for BMS’ global test
- CSL shares up 17% as immunoglobulin boost points to signs of recovery
- R1 acquiring Humata Health to bolster AI-powered prior authorizations
- Revance hires Janelle Wichmann as chief marketing officer of skincare unit
- CMI adopts orphan drug field with dedicated center of excellence
- Waist Size Is Accurate Way To Gauge Unhealthy Excess Weight, Study Says
- Panel Offers First Guidelines For Using E-Cigarettes To Help Smokers Quit
- Celcuity keeps cool amid questions about Revtorpyk launch timing
- Newsom Promotes Affordable Insulin, But California's Generic Label Off To A Slow Start
- What Geriatric Emergency Departments Do Differently
- Drive for Nuclear Power Boosts Uranium Industry — And Tribal Health Concerns in Southwest
- Rural primary care company Hopscotch clinches $53M to expand beyond NC
- Eurofins expands operations to meet growing high-potency API demand
- 24 new behavioral health projects to know
- Four health systems, including Ochsner and Denver Health, go live with Epic's real-time prior authorization checks
- 8 new psychiatric residency programs to know
- DocGo agrees to acquire virtual care provider Hicuity Health, assumes $52M debt
- Papa, eternalHealth expand partnership around Plus platform
- Happy Health secures $75M to expand AI-powered care in the home starting with sleep apnea
- As healthcare costs weigh on patients, states could play a bigger role, report finds
- Jalapeño Recalls Keep Growing As Salmonella Outbreak Investigation Continues
- Music Streaming Linked To Rise In Traffic Deaths
- EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu
- Quanovate takes back marketing claims for Mira fertility wand after P&G challenge
- Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition
- Whoop expands Advanced Labs to non-members, adds Grail’s multi-cancer detection test to lineup
- Quartz Countertop Workers Are Falling Prey To Lung Disease
- Kaiser Permanente notches 4.6% Q2 operating margin, $5.3B net income
- Epic faces Federal Trade Commission antitrust investigation, Reuters reports
- Innovaccer, Mastek ink strategic partnership to scale agentic AI in healthcare globally
- Sandoz strikes $322M biosimilars deal with Shanghai Henlius
- Argenx heads to FDA with Vyvgart after ph. 3 win in potential blockbuster autoimmune indication
- Many Smokers Unaware Of Heart, Brain Risks Of Smoking
- Tylenol, Other Medications Fuel Spike In Liver Damage Cases, Poison Center Data Says
- AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure
- My Husband Was Kicked Out Of Hospice For Dying Too Slowly
- Tadalafil (Cialis), Used for BPH and ED, Might Increase Glaucoma Risk, Study Says
- Kennedy’s Quiet Hunt for Autism Culprits Stalls as Trump Orders Baseless Changes to Childhood Shots
- Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start
- Inside agency view: Real Chemistry’s Frank Mazzola on audience nuance and rewarding creativity
- Abridge expands AI decision support to more clinicians in bid to become healthcare's copilot
- Danish politicians call out Eli Lilly obesity campaign
- Universal Health Services closes $835M Talkspace acquisition
- Gounder Brings Clarity to Egg Freezing, AI Virus Creation, and New Trump Vaccine Order
- States Enact Emergency Orders On Kratom While Awaiting Federal Rules
- Study examines how ICHRA adoption could help stabilize ACA risk pools
- Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
- Screen Time Is Not All Bad For Kids' Brains
- Processed Foods Linked To Prostate Cancer Risk
- Updated Statement Regarding the Division of Corporation Finance’s Role in the Exchange Act Rule 14a-8 Process
- It's BMS vs. Celgene investors once more after US appeals court revives lawsuit
- Industry Voices—AI should help cancer patients survive the healthcare system
- Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
- Sleep Disturbances Linked To Genetic Alzheimer's Risk
- Pre-K Sets Kids Up For School Success, Study Says
- Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- People With Disabilities Say Medicaid Income Limits Stifle Career Advancement
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- It's crunch time for Karyopharm as company faces potential default next month
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- How consumerization is reshaping pharma marketing
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- FDA Wants More Information From Food Makers On New Food Chemicals
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Beyond Compliance: Rethinking No Surprises Act strategy
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
Michigan healthcare freedom community forum
Erica G. Schwartz is a retired rear admiral in the U.S. Public Health Service Commissioned Corps who was Deputy Surgeon General from January 2019 to April 2021:
Trump nominates former deputy surgeon general as CDC director
By Yasmeen Abutaleb and Julie Steenhuysen - April 16, 2026Summary
- Position has been open since Susan Monarez was fired last year
- Schwartz has been praised by former public health officials
- Nominated healthcare executive Sean Slovenski as deputy director
WASHINGTON, April 16 (Reuters) - U.S. President Donald Trump said on Thursday he would nominate Erica Schwartz, who had served as deputy surgeon general during the COVID-19 pandemic, to become director of the Centers for Disease Control and Prevention following multiple leadership shakeups at the health agency.
Schwartz, who served during Trump's first term, was involved in the federal COVID response, helping to coordinate national preparedness and public health efforts.
The nomination represents a far more traditional pick for the embattled health agency, as the White House seeks to focus on more popular issues such as lowering drug prices and food safety, rather than Health Secretary Robert F. Kennedy Jr.'s controversial vaccine policies with Republicans bracing for a difficult November midterm election. At a pair of congressional hearings on Thursday, Kennedy largely avoided questions about vaccines.
Trump, in a post on Truth Social, also said he was naming healthcare executive Sean Slovenski as CDC deputy director and chief operating officer, Texas Health Commissioner Jen Shuford as CDC deputy director and chief medical officer and FDA official Sara Brenner as senior counselor for public health to Kennedy.
The nominations come after a Massachusetts judge blocked key parts of Kennedy's effort to reshape U.S. vaccine policy, including a move to reduce the number of shots routinely recommended for children, and his overhaul of a CDC advisory committee on inoculations.
If approved, Schwartz would lead the Atlanta-based agency, which tracks and responds to domestic and foreign threats to public health. The CDC director traditionally has the final say on U.S. vaccine policy.
She would report to Kennedy, who has long questioned the safety of vaccines, contrary to established science.
Trump fired CDC Director Susan Monarez last August over her objections to vaccine policy changes planned by Kennedy. Her position was filled by two acting directors: Health and Human Services Deputy Secretary Jim O'Neill, who was succeeded in February by Jay Bhattacharya, the director of the U.S. National Institutes of Health.
MORE TRADITIONAL CANDIDATES
Schwartz, who does not have a widely publicized position on vaccines, has been praised by former public health officials who have been critical of Kennedy's vaccine policies.
Demetre Daskalakis, former CDC director of the National Center for Immunization and Respiratory Diseases who resigned after Monarez's firing, said Schwartz showed "good leadership" during the COVID response and has a "proven track record... notably with pandemic preparedness."
Polls have shown most voters disapprove of Kennedy's moves to overhaul the childhood vaccination schedule.
The White House has pushed for more traditional candidates for top agency roles after Kennedy handpicked a slate of controversial political appointees who have undermined trust in vaccines, according to sources familiar with the discussions.
Close Kennedy ally and vaccine injury lawyer Aaron Siri was critical of the nomination.
"Her long track record of directly issuing rights-crushing civilian and military vaccine mandates, including mandating injection of smallpox, anthrax, and flu vaccines into U.S. Forces, and disciplining those that refused, reflects she lacks the basic ethics and morals to lead the CDC," Siri said. "This agency does not need another cheerleader for industry."
The Erica Schwartz nomination was actually Secretary Kennedy's:
https://thehill.com/policy/healthcare/5841154-kennedy-trump-cdc-nominee/
RFK Jr. says he did not speak to Trump about CDC nominee
By Nathaniel Weixel - April 21, 2026Health Secretary Robert F. Kennedy Jr. did not speak to President Trump about nominating Erica Schwartz to lead the Centers for Disease Control and Prevention, he told lawmakers Tuesday.
Kennedy told a House Energy and Commerce subcommittee that he met with Schwartz on “multiple occasions” prior to her being tapped as the new nominee, including to discuss her views on vaccinations.
But Kennedy said it was HHS chief counselor Chris Klomp who spoke with Trump about the nomination. He also said HHS suggested Schwartz as a candidate to the White House.
Klomp was elevated to the agency’s No. 2 spot in February, reportedly to help the White House instill a stabilizing force and message discipline at HHS ahead of the midterm elections.
Schwartz, who served as deputy surgeon general during the first Trump administration and spent much of her career in health roles in the U.S. military, has no public ties to the anti-vaccine movement.
Public health leaders and advocates breathed sighs of relief when Trump announced her as the nominee late last week, and her nomination was seen as a clear sign that the administration is putting pressure on Kennedy to sideline his controversial vaccine policies due to political concerns in an election year.
But there is concern that Schwartz will need to be granted full autonomy from Kennedy to succeed in steadying the CDC and reinforcing its reputation as the leading scientific and public health agency.
Her predecessor, Susan Monarez, boasted similar public health credentials but was fired after less than a month on the job because she clashed with Kennedy over vaccine moves.
Under questioning from Rep. Raul Ruiz (D-Calif.), Kennedy declined to commit to implementing any vaccine guidance issued by Schwartz.
“You’ll probably fire her” like Monarez, Ruiz said, “because you will not accept recommendations based on science.”
Kennedy then denied he had been sidelined by the White House.
“That’s not true,” Kennedy said. “You’re not getting truths.”
“How does that make you feel, Mr. Secretary?” Ruiz continued. “You must be aware of that. It must be nerve-wracking, especially after AG [Pam] Bondi, and Secretaries [Kristi] Noem and [Lori] Chavez-Deremer were fired for making the president look bad.”
“You’re making stuff up,” Kennedy shot back.
Dr. Erica Schwartz Was Confirmed As CDC Director Today:
https://nypost.com/2026/08/05/us-news/dr-erica-schwartz-confirmed-as-cdc-director/
Dr. Erica Schwartz confirmed as CDC director following monthslong vacancy
By Associated Press - August 5, 2026The Senate on Wednesday confirmed Dr. Erica Schwartz as director of the Centers for Disease Control and Prevention, placing her in charge of a public health agency beleaguered by political meddling and low morale.
Schwartz was confirmed in a 51-44 vote. The 54-year-old becomes the 22nd leader of the Atlanta-based CDC, which is charged with protecting Americans from preventable health threats, and the agency’s first confirmed director in nearly a year. Her resume includes medical and law degrees, a stint as deputy surgeon general, and a leadership position at the U.S. Coast Guard.
Schwartz’s nomination appeared to be on shaky ground after a hearing before the Senate Health, Education, Labor and Pensions Committee last month. The chairman, Sen. Bill Cassidy, R-La., and others questioned whether she would be willing to stand up to Republican President Donald Trump’s health secretary, Robert F. Kennedy Jr., if he ordered CDC to do something unsupported by science and good public health practice.
But weeks later, Cassidy said he had spoken with Schwartz after that hearing and with others who knew her, and said he had gained confidence in her.
The CDC has been in turmoil since Trump returned to office last year.
Largely due to layoffs and resignations, the agency has lost 3,000-plus employees, more than one-quarter of its workforce. Morale has plummeted as a succession of mostly temporary leaders have come and gone. The front office has been staffed by political appointees with little or no training in medicine or public health.
When Schwartz was nominated in April, public health experts were cautiously optimistic, citing her background. They also noted Schwartz was the choice of Trump and not Kennedy, who is a leading voice in the anti-vaccine movement before he was tapped to oversee the CDC and other federal health agencies.
Schwartz was the third Trump nominee for CDC director in the past 18 months.
The first was a former Florida congressman, Dr. David Weldon. His Senate hearing in March 2025 was canceled an hour before it was to begin. Weldon said at the time that he had been told not enough senators were willing to vote for him.
The White House then moved on to Susan Monarez, who had been serving as the CDC’s acting director. Monarez was confirmed by the Senate, but ousted from the job in less than a month. Trump administration officials said she was not aligned with the president’s agenda, so they terminated her.
Since then, there have been a series of HHS officials as acting CDC director.
The CDC position was one of several leadership vacancies among federal health agencies, including the U.S. surgeon general and the commissioner of the Food and Drug Administration.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























